Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

Drug Eruption and Interactions - PHARMACEUTICAL REVIEW Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

pharmareview.files.wordpress.com
from pharmareview.files.wordpress.com More from this publisher
02.06.2013 Views

Other Anaphylactoid reactions/Anaphylaxis (

102 CEFEPIME Erythema multiforme Exanthems (1.8%) Pruritus (1–10%) (1993): Giamarellou H, J Antimicrob Chemother 32 Suppl B, 123 (2%) (1993): Jauregui L+, J Antimicrob Chemother 32 Suppl B, 141 (1993): Mouton Y+, J Antimicrob Chemother 32 Suppl B, 133 (4%) Rash (sic) (51%) (2001): Mustafa MM+, Pediatr Infect Dis J 20(3), 362 (2000): Sheng WH+, J Microbiol Immunol Infect 33, 109 (1996): Holloway WJ+, Am J Med 100, 52S (1995): Schrank JH+, Clin Infect Dis 20(1), 56 (1994): Okamoto MP+, Am J Hosp Pharm 51, 463 (1993): Barckow D+, J Antimicrob Chemother 32 Suppl B, 187 (1993): Giamarellou H, J Antimicrob Chemother 32 Suppl B, 123 (2%) (1993): Mouton Y+, J Antimicrob Chemother 32 Suppl B, 133 (4%) (1993): Newton ER+, J Antimicrob Chemother 32 Suppl B, 195 Stevens–Johnson syndrome Toxic epidermal necrolysis Urticaria (1.8%) (1993): Mouton Y+, J Antimicrob Chemother 32 Suppl B, 133 (4%) Mucosal Oral candidiasis Vaginitis (

Other<br />

Anaphylactoid reactions/Anaphylaxis (

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!